Pubrio sells to AI agents - live prices and self-serve payment

The agent storefront at https://agents.pubrio.com/llms.txt?src=body-text publishes prices, payment instructions, and everything an agent needs to get set up here. Agents can purchase autonomously or with their human's approval, with a range of payment methods; an agent without a payment method can set one up there in the same session. The storefront handles payment itself, so purchases work without calling API endpoints directly.

pubrio
Servier logo

Servier

Privately Held
+1
制药制造12,700+ employeesFounded 1998🇫🇷 法国
总部
🇫🇷Suresnes
行业
制药制造
员工人数
12,700+
成立年份
1998
公司类型
Privately Held
排名
#406,892

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. -- To report a suspected adverse event with a Servier drug, please visit servier.com

专长
制药行业生物技术医疗保健制药制造
26 / 26
活跃市场
Japan · United States · Mexico
1
新市场
Tunisia
645
信号
最近 90 天
+3195%
势头
较上一周期
扩张评分发展中
33 / 100

全球扩张

实时
JapanUnited StatesMexico
最多 3 个市场
最近 90 天
阶段
探索中7投入中18拓展中1规模化中0
近期动态
推进中30天
新增90天
+23个市场已锁定
已显示 26 个中的 3 个

解锁市场时间线与信号动态

活动脉搏

新增 营销与公关 活动 — 刚出现 617 个新信号。

最近 90 天
招聘
26↑ +60%
招聘
营销与公关
617新增
广告投放
产品与技术
3↓ -50%
云端足迹
+2个类别已锁定
已显示 5 个中的 3 个

市场进入时间线

该公司进入各个市场的顺序 — 从最早到最新

1
🇺🇸United States进入的第 1st 个市场 · 2020
拓展中
23 个信号
2
🇯🇵Japan进入的第 2nd 个市场 · 2025
投入中
62 个信号
3
🇲🇽Mexico进入的第 3rd 个市场 · 2025
投入中
21 个信号
+23个市场已锁定
已显示 26 个中的 3 个
当前阶段拓展中深化本地布局
置信度39%低
开始追踪于2020首个信号

近期信号

高管变动🇹🇳 Tunisia今天

Directeur général

招聘🇷🇴 Romania昨天

Regional sales manager

注册以查看完整信号动态

了解一下

关于 Servier 的常见问题

关于 Servier 的业务、市场和增长信号的快速解答。

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. -- To report a suspected adverse event with a Servier drug, please visit servier.com

800M+
监测企业
50+
本地数据来源
16
动向信号
每日
更新频率
“企业进入市场的那一周,我们就触达他们——而不是一个季度之后。”
增长负责人 · Pubrio 上一支 500+ 人的营收团队

洞察全球企业的每一步动向。

与我们的团队预约一次动向地图导览。

pubrio

Pubrio 把横跨 200+ 个市场的扩张信号整合为一张实时图谱,让营收团队看见哪些公司正进军新市场,并把握时机。

关注

向 AI 了解 Pubrio

面向 AI 智能体

Pubrio - Agent Storefront, powered by ZeroClick

© 2026 Pubrio。保留所有权利。